Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer

Oncology

Volumn 80, Issue 5-6, 2011, Pages 289-295

  Shi, Chunmei ^a   Yang, Baoyu ^a   Chen, Qiang ^a   Yang, Jianwei ^b   Fan, Nanfeng ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

Author keywords

Advanced gastric cancer; Intraperitoneal perfusion chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; FLOXURIDINE; FLUOROURACIL; TEGAFUR;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; BONE MARROW DEPRESSION; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RELAPSE; CARCINOMATOUS PERITONITIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LEUKOPENIA; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; NAUSEA AND VOMITING; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STOMACH CANCER; THROMBOCYTOPENIA;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTRECTOMY; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 79960502224     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000329075     Document Type: Article

References (15)

1. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77: 436-439. (Pubitemid 20119386)
2. Lee CC, Lo SS, Wu CW, Shen KH, Li AF, Hsieh MC, Lui WY: Peritoneal recurrence of gastric adenocarcinoma after curative resection. Hepatogastroenterology 2003; 50: 1720-1722. (Pubitemid 37186572)
3. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003; 90: 1113-1119. (Pubitemid 37152170)
4. Bozzetti F, Yu W, Baratti D, Kusamura S, Deraco M: Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 2008; 98: 273-276.
5. Yu W: A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal perfusion chemotherapy. Eur J Surg Oncol 2006; 32: 655-660. (Pubitemid 44063997)
6. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007; 14: 2702-2713. (Pubitemid 47460649)
7. Scaringi S, Kianmanesh R, Sabate JM, et al: Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal perfusion chemotherapy: A single western center experience. Eur J Surg Oncol 2008; 34: 1246-1252.
8. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, François Y, Vignal J, Gilly FN: Cytoreductive surgery and intraperitoneal chemotherapy hyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004; 139: 20-26. (Pubitemid 38049613)
9. Cheong JH, Shen JY, Song CS, Hyung WJ, Shen JG, Choi SH, Noh SH: Early postoperative intraperitoneal perfusion chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer. Ann Surg Oncol 2007; 14: 61-68. (Pubitemid 44954271)
10. Dedrick RL, Flessner MF: Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure. J Natl Cancer Inst 1997; 89: 480-487. (Pubitemid 27147264)
11. Wu TY, Wang KC, Chen Z, Zhao Y, Zhang JQ, Guo L, Yu MN, Wang JY, Dang XY: Clinic study on peritoneal chemotherapy after operation of advanced gastric cancer. Chin Clin Oncol 2002; 7: 467-468.
12. Ma B, Huang SX, Chen C: The application of early continuous hyperthemic peritoneal perfusion chemotherapy in treatment for advanced gastric cancer after operation. Chin Cancer 2006; 5: 276-277.
13. Adam YG, Efron G: Trends and controversies in the management of carcinoma of the stomach. Surg Gynecol Obstet 1989; 169: 371.
14. Sugarbaker PH, Yu W, Yonemura Y: Gastrectomy, peritonectomy and perioperative intraperitoneal perfusion chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003; 21: 23-24.
15. Xue SL, Hu ML: Catheter-related complications in postoperative intraperitoneal chemotherapy for gastric cancer. Chin J Cancer Res 2007; 19: 222-226.